Strumento inattivo

Azioni Vitae Pharmaceuticals Inc

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Vitae Pharmaceuticals : Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae	17/10/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Shareholders To Contact The Firm For Additional Information	15/09/16
Brower Piven Commences An Investigation Into The Proposed Sale Of Vitae Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information	15/09/16
NASDAQ Comp : Wall Street termine dans le rouge, Apple monte encore	14/09/16
Vitae Pharmaceuticals : Allergan to Acquire Vitae Pharmaceuticals Adding Innovative Development Programs for Dermatologic Conditions	14/09/16

Dirigenti	Titolo	Età	Da
Ambrose Bailey PSD	President	60	25/10/16
Carole A. Sable CTO	Chief Tech/Sci/R&D Officer	62	06/06/16
John Grosso BRD	Director/Board Member	-	-

Amministratori	Titolo	Età	Da
John Grosso BRD	Director/Board Member	-	-

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-2,47%	88,14 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+1,45%	40,44 Mrd
BIOGEN INC.	-14,43%	32,24 Mrd
UCB	+52,47%	24,39 Mrd
BIOMARIN PHARMACEUTICAL INC.	-14,85%	15,59 Mrd
INCYTE CORPORATION	-13,87%	12,14 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-7,87%	12,18 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-39,40%	12,3 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+5,09%	8,87 Mrd